CVS Health Shares Are Trading Higher After Cowen Maintained Its Buy Rating and Raised Its Price Target From $73 to $80. Piper Sandler Also Maintained Its Overweight Rating, but Lowered Its Price Target From $72 to $64.
CVS Health Shares Are Trading Higher After Cowen Maintained Its Buy Rating and Raised Its Price Target From $73 to $80. Piper Sandler Also Maintained Its Overweight Rating, but Lowered Its Price Target From $72 to $64.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated